Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. Vildagliptin works by blocking the breakdown of incretin hormones in the body. Vildagliptin is an orally active antihyperglycemic agent. Vildagliptin works to improve glycemic control in type II diabetes mellitus by enhancing the glucose sensitivity of beta-cells. Vildagliptin Degradation impurity, Vildagliptin Process impurity, Vildagliptin Potential impurity, Vildagliptin USP Related Compound, Vildagliptin N-Nitroso impurity, Vildagliptin nitrosamine impurity etc. are listed below